You are here

Industry News

Advamed Smart Brief

August 22, 2017
Carl Zeiss Meditec paid an undisclosed amount for Veracity Innovations, a cloud-based ophthalmological technology developer.  -More
August 22, 2017
Financing worth $8 million was secured by Carmel, Ind.-based medtech company FAST BioMedical from the NIH and a single family -More
August 22, 2017
An agreement was reached by Laboratory Corp.  -More
August 22, 2017
Australian medtech firm Anatomics entered into a deal with Singapore's Nanyang Technological University to accelerate researc -More
August 22, 2017
A series of reports from iData Research predicts the US market for orthopedic small bone and joint devices will hit $4 billio -More
August 22, 2017
Wearable technology is moving beyond consumer-grade health and wellness devices.  -More
August 22, 2017
The FDA has granted BioVentrix an investigational device exemption approval to conduct a trial evaluating the safety and effi -More
August 22, 2017
The ProxiSure laparoscopic suturing device was released by Johnson & Johnson subsidiary Ethicon.  -More
August 22, 2017
The FDA gave Creo Medical Group 510(k) clearance for the Speedboat RS2 device and the CROMA platform 49 days after the compan -More
August 22, 2017
Biotronik obtained approval from the FDA for its Edora HF-T QP magnetic resonance-conditional quadripolar cardiac resynchroni -More

Industry News

PR Newswire
Bio2 Medical today announced the results of the Angel® Catheter pivotal study, "Evaluation of a Device Combining an Inferior Vena Cava Filter and a Central Venous Catheter for Preventing Pulmonary Embolism Among Critically Ill Trauma Patients," published in the Journal of Vascular and Interventional Radiology (JVIR).  The Angel® Catheter met all safety endpoints and demonstrated a significant reduction in clinically significant and fatal pulmonary embolism (PE). The novel device was tested in a...
RealClear Health
Often undiagnosed, an estimated two to six million people in the United States have a serious heart condition called atrial fibrillation, or AFib. As those living with the disease know, complications from the irregular heartbeat caused by the AFib can be potentially devastating: The average person with AFib is five times more likely to suffer a stroke than someone with a regular heartbeat. Fortunately, there is innovative medical technology available today poised to make a real difference in...
Legal Backgrounder
When a doctor implants a medical device, he or she often requests the presence of a representative of the device manufacturer (a “rep”) in the operating room. Some observers are critical of this practice, demanding thatreps be barred from the O.R. At the same time,some lawyersthink repsin the O.R.should be subject to liability in the court system. This Legal Backgrounder explains why reps often play an important, if limited, role in the O.R., and why that role should not expose reps to lawsuits
Business Wire
ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today the closing of a $36 million Series C financing, including existing convertible notes. The round was led by Philips and UPMC, through its innovation and commercialization arm UPMC Enterprises, with other new and existing investors participating. The funding will support a planned US-based pivotal trial for...
Washington Examiner
Imagine for a moment that you are one of the approximately 44 million women in the U.S. affected by cardiovascular disease, or one of the 24 million with osteoarthritis. You'd want access to the most advanced and effective care. Oftentimes, your doctor would recommend a medical technology or device as an essential component of your treatment – placing a stent in a blocked artery or replacing your knee or hip with a new artificial one, for example. ​​​​​​